Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternate-day corticosteroid regimen in children with active Crohn's disease (pilot RCT feasibility study)
2010-022017-26Phase 2Terminated
- Sponsor
- Central Manchester University Hospitals NHS Foundation Trust
- Start
- Dec 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of prednisolone in Crohn's disease (2 arms), sponsored by Central Manchester University Hospitals NHS Foundation Trust. Primary endpoint: Clinical Remission. Started Dec 2010; status: terminated.
02
Drugs
prednisolone
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2010-022017-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022017-26.